Biogen (BIIB)

Depreciation & Amortization

$236.10M

Quarterly · Period ending: · USD

BIIB logo

BIIB Depreciation & Amortization

Latest reported$236.10M
BIIB Quarterly Depreciation & Amortization (-$1.10M → $236.10M)
High-resolution chart · PNG

BIIB depreciation & amortization history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Depreciation & Amortization — Quarterly (USD)
Period endingDepreciation & Amortization (USD)
236,100,000
204,400,000
200,200,000
202,200,000
194,300,000
183,200,000
184,000,000
182,800,000
158,900,000
147,500,000
140,100,000
125,000,000
117,400,000
112,300,000
119,800,000
120,700,000
134,800,000
143,100,000
134,700,000
133,200,000
117,200,000
102,600,000
109,500,000
114,700,000
112,900,000
119,900,000
113,000,000
113,500,000
117,000,000
121,100,000
153,000,000
157,200,000
171,500,000
168,900,000
177,800,000
177,400,000
182,600,000
512,000,000
177,400,000
180,200,000
175,400,000
149,700,000
156,300,000
151,600,000
144,600,000
147,900,000
157,642,000
175,406,000
164,139,000
190,963,000
158,383,000
147,477,000
128,427,000
97,453,000
96,876,000
94,203,000
90,624,000
83,945,000
88,721,000
87,367,000
90,300,000
92,545,000
94,012,000
90,128,000
87,451,000
82,510,000
93,200,000
85,884,000
126,731,000
122,146,000
122,017,000
127,571,000
105,539,000
106,932,000
102,263,000
96,755,000
92,460,000
88,815,000
87,217,000
89,731,000
75,692,000
123,230,000
97,524,000
109,751,000
98,822,000
96,111,000
106,459,000
129,634,000
101,556,000
101,786,000
16,414,000
3,857,000
3,003,000
3,100,000
13,743,000
10,827,000
30,976,000
10,446,000
8,800,000
46,183,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.